cholestyramine resin has been researched along with dacarbazine in 1 studies
Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (dacarbazine) | Trials (dacarbazine) | Recent Studies (post-2010) (dacarbazine) |
---|---|---|---|---|---|
2,669 | 342 | 190 | 7,556 | 1,463 | 3,429 |
Protein | Taxonomy | cholestyramine resin (IC50) | dacarbazine (IC50) |
---|---|---|---|
Matrix metalloproteinase-9 | Homo sapiens (human) | 0.556 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adeyi, O; Fung, S; Mason, M; Millar, BA | 1 |
1 other study(ies) available for cholestyramine resin and dacarbazine
Article | Year |
---|---|
Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Biopsy, Needle; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestyramine Resin; Common Bile Duct Diseases; Dacarbazine; Female; Follow-Up Studies; Glioblastoma; Humans; Immunohistochemistry; Jaundice; Liver Function Tests; Middle Aged; Syndrome; Temozolomide; Treatment Outcome; Ursodeoxycholic Acid | 2014 |